Penta-O-galloyl-β-D-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in Caki-2 renal cancer cells.

[1]  Soo-Jin Jeong,et al.  Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition. , 2011, Carcinogenesis.

[2]  G. Türk,et al.  Lycopene and ellagic acid prevent testicular apoptosis induced by cisplatin. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  J. Lieske,et al.  1,2,3,4,6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model. , 2011, Kidney international.

[4]  Soo-Jin Jeong,et al.  Reactive oxygen species involved in sulforaphane-induced STAT3 inactivation and apoptosis in DU145 prostate cancer cells , 2010 .

[5]  Soo-Jin Jeong,et al.  1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells. , 2010, Biological & pharmaceutical bulletin.

[6]  Soo-Jin Jeong,et al.  Penta-O-galloyl-β-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of P21 cyclin-dependent kinase inhibitor 1A, P27 cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple-negative xenograft growth , 2010, Breast Cancer Research.

[7]  Soo-Jin Jeong,et al.  Paeonol Oxime Inhibits bFGF-Induced Angiogenesis and Reduces VEGF Levels in Fibrosarcoma Cells , 2010, PloS one.

[8]  J. Lieske,et al.  Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells. , 2010, Biological & pharmaceutical bulletin.

[9]  T. Chou.  Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[10]  S. Saleh,et al.  Protective Effects of the Angiotensin II Receptor Blocker Losartan on Cisplatin-Induced Kidney Injury , 2009, Chemotherapy.

[11]  Soo-Jin Jeong,et al.  Protective effect of Bojungbangdocktang on cisplatin-induced cytotoxicity and apoptosis in MCF-10A breast endothelial cells. , 2009, Environmental toxicology and pharmacology.

[12]  Sara Khan,et al.  Studies on the protective effect of green tea against cisplatin induced nephrotoxicity. , 2009, Pharmacological research.

[13]  B. Molitoris,et al.  siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.

[14]  Sung-Hoon Kim,et al.  Anti-Cancer, Anti-Diabetic and Other Pharmacologic and Biological Activities of Penta-Galloyl-Glucose , 2009, Pharmaceutical Research.

[15]  Sang Kook Lee,et al.  Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin‐treated mice , 2009, Phytotherapy research : PTR.

[16]  Jen-kun Lin,et al.  Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression. , 2009, Journal of agricultural and food chemistry.

[17]  J. Lieske,et al.  Rhus verniciflua Stokes prevents cisplatin-induced cytotoxicity and reactive oxygen species production in MDCK-I renal cells and intact mice. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[18]  B. de Camargo,et al.  Omission of Day 2 of Antiemetic Medications is a Cost Saving Strategy for Improving Chemotherapy-Induced Nausea and Vomiting Control: Results of a Randomized Phase III Trial , 2009, American journal of clinical oncology.

[19]  Cheng Jiang,et al.  Penta-1,2,3,4,6-O-galloyl-β-d-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo , 2008, Molecular Cancer Therapeutics.

[20]  Sang Kook Lee,et al.  The extract of Prunus persica flesh (PPFE) attenuates chemotherapy‐induced hepatotoxicity in mice , 2008, Phytotherapy research : PTR.

[21]  Y. Kashiwada,et al.  Inhibition of P‐glycoprotein function by tannic acid and pentagalloylglucose , 2007, The Journal of pharmacy and pharmacology.

[22]  Y. Masubuchi,et al.  Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs , 2007, Critical reviews in toxicology.

[23]  Sung-Hoon Kim,et al.  DMNQ S‐64 Induces Apoptosis via Caspase Activation and Cyclooxygenase‐2 Inhibition in Human Nonsmall Lung Cancer Cells , 2007, Annals of the New York Academy of Sciences.

[24]  J. Lieske,et al.  Renal cell adaptation to oxalate , 2005, Urological Research.

[25]  Y. Surh,et al.  Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. , 2005, Carcinogenesis.

[26]  Y. Gho,et al.  1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor. , 2004, Cancer letters.

[27]  Jen-kun Lin,et al.  Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). , 2003, Biochemical pharmacology.

[28]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[29]  S. Lowe,et al.  Dissecting p53 tumor suppressor functions in vivo. , 2002, Cancer cell.

[30]  K. Chai,et al.  In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. , 2001, Cancer letters.

[31]  R. Fine,et al.  Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis , 2000, Oncogene.

[32]  E. Wagner,et al.  The Mammalian UV Response c-Jun Induction Is Required for Exit from p53-Imposed Growth Arrest , 2000, Cell.

[33]  K. Golka,et al.  Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system , 2000, Archives of Toxicology.

[34]  D. Green,et al.  p53 Induces Apoptosis by Caspase Activation through Mitochondrial Cytochrome c Release* , 2000, The Journal of Biological Chemistry.

[35]  S. Lin-Shiau,et al.  Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. , 1999, European journal of pharmacology.

[36]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[37]  N. Mulder,et al.  Modulation of cis-diamminedichloroplatinum(II) resistance: a review. , 1992, British Journal of Cancer.

[38]  G. G. Gross,et al.  Biosynthesis of gallotannins: formation of polygalloylglucoses by enzymatic acylation of 1,2,3,4,6-penta-O-galloylglucose. , 1990, Archives of biochemistry and biophysics.

[39]  M. John,et al.  Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of India. , 2011, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[40]  G. Kroemer.  [Mitochondrial control of apoptosis]. , 2001, Bulletin de l'Academie nationale de medecine.

[41]  H. Lorenz,et al.  A rapid and simple method for the isolation of apoptotic DNA fragments. , 1994, Nucleic acids research.

[42]  M. Maines.  Effect of cis-platinum on heme, drug, and steroid metabolism pathways: possible involvement in nephrotoxicity and infertility. , 1990, Critical reviews in toxicology.

[43]  T. F. Patton,et al.  Pharmacokinetics of intact cisplatin in plasma. Infusion versus bolus dosing , 1982 .